Adagio Therapeutics board member Howard Mayer resigns effective June 24, 2022

Invivyd, Inc.

Howard Mayer, M.D. resigned from the board and all committees, effective June 24, 2022.
Resignation was not due to any disagreement with the company's operations, policies, or practices.
No replacement director was announced in the filing.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Howard Mayer

Director

IVVD · Invivyd, Inc.

Effective: 2022-06-24
Filed: June 30, 2022, 7:59 PM ET

On June 24, 2022, Howard Mayer, M.D. notified Adagio Therapeutics, Inc. (the “Company”) of his decision to resign from the board of directors of the Company and all committees thereof, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Howard Mayer resigned as Director at Invivyd, Inc..

Action: resigned
Role: Director

Exact text from the filing

On June 24, 2022, Howard Mayer, M.D. notified Adagio Therapeutics, Inc. (the “Company”) of his decision to resign from the board of directors of the Company and all committees thereof, effective immediately.

View on SEC.gov

Invivyd, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-186218

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.